Mental Illness Awareness Week: Mental Health Treatments in Development

It’s Mental Illness Awareness Week, a week dedicated to  raising awareness of mental illness, which affects approximately 1 in 5 Americans in a given year.

Read more

What is Patient Centricity in Clinical Trials?

What is patient centricity?

Patient centricity means designing a treatment, clinical trial or other health solution around the patient. Creating a patient-centric solution involves getting feedback from patients themselves and making decisions based on their needs and perspectives.

Read more

Clinical Trial Phases: What are Clinical Trial Phases?

What are Clinical Trial Phases?

In order to reach patients, every drug must make its way through four clinical trial phases. Each clinical trial phase has a different goal and separate hurdles to clear before a potential new treatment can move forward.

Read more

Clinical Trials as an Option in Mesothelioma Treatment

A Guest Post from the Mesothelioma + Asbestos Awareness Center for Mesothelioma Awareness Day

Read more

Medicine X 2017: Hearing Stories of Patient Advocacy and Empowerment

Our team recently returned from the most patient-centric conference we’ve ever attended: Medicine X. Hosted by Stanford Medicine, this year’s conference focused on the theme “Citizen.” Panels and talks centered around the impact we as citizens can make on health care outcomes for everyone.

Read more

Reflections on Research from Alzheimer’s Organizations

In our work connecting patients to trials, we’ve partnered with dozens of Alzheimer’s organizations to ensure that our search tool is available when and where patients are looking for information. For World Alzheimer’s Day, we asked a few of these organizations to weigh in on two key questions pertaining to Alzheimer’s research and the future of Alzheimer’s treatment. Thanks to our participants for your words of wisdom:

Read more

Alzheimer's Research News Round-Up

Alzheimer’s research news today

Alzheimer’s research has been frustratingly slow for the 5.5 million people living with in the disease in the United States.

Read more

What is Mild Cognitive Impairment (MCI)?

What is Mild Cognitive Impairment?

Mild cognitive impairment (MCI) causes slight but noticeable memory changes and thinking problems. These thinking problems are worse than those associated with normal aging, but not as severe as Alzheimer’s disease memory loss symptoms.

Read more

Innovation Conference Recap: RSM Medical Innovations Summit

The Antidote team presented on how we’re helping medical researchers make progress, faster at the latest innovation conference

Over the weekend, Antidote’s VP of Engineering, Dean Sellis, and our Entrepreneur-in-Residence, Ed Godber, attended a favorite innovation conference: the Royal Society of Medicine’s Medical Innovations Summit. They were thrilled with the diverse array of topics covered and the fascinating group of innovators who attended, and they were happy to share perspective on the current state of medical research, and what Antidote is doing to change it.

Read more

Pharma Conference Reflections: DPharm 2017

Antidote executives discussed a whole new approach to patient engagement at the latest pharma conference, DPharm 2017.

Last week, we were honored to be Executive Sponsors at at the 7th Annual DPharm: Disruptive Innovations to Advance Clinical Trials conference in Boston. DPharm is a leading pharma conference that brings together innovators involved with clinical trials to share and discuss the latest ideas. Last week's event hosted more than 400 of the industry's most creative thinkers.

Read more